Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study.

Bifulco G, Di Spiezio Sardo A, De Rosa N, Greco E, Spinelli M, Di Carlo C, Tommaselli GA, Nappi C.

Gynecol Endocrinol. 2012 Dec;28(12):949-55. doi: 10.3109/09513590.2012.683078. Epub 2012 May 10.

PMID:
22571602
2.

Estradiol valerate/dienogest: a novel combined oral contraceptive.

Borgelt LM, Martell CW.

Clin Ther. 2012 Jan;34(1):37-55. doi: 10.1016/j.clinthera.2011.11.006. Epub 2011 Dec 14. Review.

PMID:
22169052
3.

Endometrial preparation with estradiol plus dienogest (Qlaira) for office hysteroscopic polypectomy: randomized pilot study.

Cicinelli E, Pinto V, Quattromini P, Fucci MR, Lepera A, Mitola PC, Cicinelli MV, Annarita F, Tinelli R.

J Minim Invasive Gynecol. 2012 May-Jun;19(3):356-9. doi: 10.1016/j.jmig.2011.12.020. Epub 2012 Feb 9.

PMID:
22322156
4.

Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.

Grandi G, Xholli A, Napolitano A, Palma F, Cagnacci A.

Reprod Sci. 2015 May;22(5):626-32. doi: 10.1177/1933719114556488. Epub 2014 Nov 13.

PMID:
25394646
5.

Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.

Fraser IS, Jensen J, Schaefers M, Mellinger U, Parke S, Serrani M.

Contraception. 2012 Aug;86(2):96-101. doi: 10.1016/j.contraception.2011.11.011. Epub 2012 Jan 10.

PMID:
22240178
6.

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.

Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.

Contraception. 2009 Nov;80(5):436-44. doi: 10.1016/j.contraception.2009.03.018. Epub 2009 May 13.

PMID:
19835717
7.

Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).

Nappi RE, Terreno E, Sances G, Martini E, Tonani S, Santamaria V, Tassorelli C, Spinillo A.

Contraception. 2013 Sep;88(3):369-75. doi: 10.1016/j.contraception.2013.02.001. Epub 2013 Feb 28.

PMID:
23453784
8.
10.

Efficacy of dienogest in thinning the endometrium before hysteroscopic surgery.

Kodama M, Onoue M, Otsuka H, Yada-Hashimoto N, Saeki N, Kodama T, Wakasa T, Funato T.

J Minim Invasive Gynecol. 2013 Nov-Dec;20(6):790-5. doi: 10.1016/j.jmig.2013.04.020. Epub 2013 Jul 5.

PMID:
23830718
11.

Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.

De Leo V, Fruzzetti F, Musacchio MC, Scolaro V, Di Sabatino A, Morgante G.

Contraception. 2013 Sep;88(3):364-8. doi: 10.1016/j.contraception.2012.09.003. Epub 2013 Jun 13.

PMID:
23769016
12.

Estradiol valerate/dienogest: a novel oral contraceptive.

Whalen KL, Rose R.

Ann Pharmacother. 2011 Oct;45(10):1256-61. doi: 10.1345/aph.1Q216. Epub 2011 Sep 13. Review.

PMID:
21917554
13.

Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.

Caruso S, Agnello C, Romano M, Cianci S, Lo Presti L, Malandrino C, Cianci A.

J Sex Med. 2011 Oct;8(10):2841-50. doi: 10.1111/j.1743-6109.2011.02409.x. Epub 2011 Aug 2.

PMID:
21810188
14.

Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation.

Paoletti AM, Lello S, Di Carlo C, Orrù M, Malune ME, Neri M, Pilloni M, Zedda P, D'Alterio MN, Motzo C, Melis GB, Cagnacci A.

Gynecol Endocrinol. 2016;32(1):61-4. doi: 10.3109/09513590.2015.1079175. Epub 2015 Sep 15.

PMID:
26370625
15.

Estradiol valerate/dienogest.

Wellington K, Perry CM.

Drugs. 2002;62(3):491-504; discussion 505-6. Review.

PMID:
11827562
16.

Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women.

Blode H, Zeun S, Parke S, Zimmermann T, Rohde B, Mellinger U, Kunz M.

Contraception. 2012 Oct;86(4):337-44. doi: 10.1016/j.contraception.2012.01.010. Epub 2012 Mar 23.

PMID:
22445438
17.

Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.

Jensen JT.

Expert Opin Pharmacother. 2010 May;11(7):1147-57. doi: 10.1517/14656561003724713. Review.

PMID:
20367275
18.

Outpatient hysteroscopic polypectomy in 237 patients: feasibility of a one-stop "see-and-treat" procedure.

Garuti G, Cellani F, Colonnelli M, Grossi F, Luerti M.

J Am Assoc Gynecol Laparosc. 2004 Nov;11(4):500-4.

PMID:
15701193
19.

Effect of four oral contraceptives on hemostatic parameters.

Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H.

Contraception. 2004 Aug;70(2):97-106.

PMID:
15288212
20.

[Association of E2v/DNG as contraceptive choice for a better quality of life of women].

Nappi RE.

Minerva Ginecol. 2012 Feb;64(1):41-52. Review. Italian.

PMID:
22334230

Supplemental Content

Support Center